Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Elizabeth Cermak currently holds 14,668 shares of Clarus Therapeutics Holdings, Inc. (CRXT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Elizabeth Cermak has been a net buyer of CRXT stock. They have purchased $46.7K and sold $0 worth of shares.
Elizabeth Cermak's most recent insider trade was on Nov 4, 2024, when they sold 10,000 shares at $0.00 per share.
Elizabeth Cermak serves as Executive at Clarus Therapeutics Holdings, Inc. (CRXT). They have executed 9 insider transactions totaling $46.7K over their tenure at the company.
Elizabeth Cermak holds the position of Executive at Clarus Therapeutics Holdings, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Elizabeth Cermak has shown a buying trading pattern, with $46.7K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Elizabeth Cermak was on Oct 1, 2011, when they purchased $67.5K worth of POZN shares. This transaction involved 28,000 shares at $2.41 per share.
Elizabeth Cermak currently owns 14,668 shares of Clarus Therapeutics Holdings, Inc. (CRXT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Elizabeth Cermak's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Elizabeth Cermak has 9 Form 4 filings on record as an insider at Clarus Therapeutics Holdings, Inc..
Set alerts for Elizabeth Cermak and 40,000+ other insiders.